Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14:48–54.

Article  PubMed  Google Scholar 

Rehman AU, Khan P, Maurya SK, Siddiqui JA, Santamaria-Barria JA, Batra SK, et al. Liquid biopsies to occult brain metastasis. Mol Cancer. 2022;21:113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, et al. Brain metastases: a Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro Oncol. 2022;24:1613–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu YB, Zhang Y, Song Z, Wang W, Shao L. Treatment and prognosis of solid and cystic brain metastases in patients with non-small-cell lung cancer. Cancer Manag Res. 2021;13:6309–17.

Article  PubMed  PubMed Central  Google Scholar 

Brigell RH, Cagney DN, Martin AM, Besse LA, Catalano PJ, Lee EQ, et al. Local control after brain-directed radiation in patients with cystic versus solid brain metastases. J Neurooncol. 2019;142:355–63.

Article  PubMed  Google Scholar 

Lin X, DeAngelis LM. Treatment of brain metastases. J Clin Oncol. 2015;33:3475–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gonçalves A. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res. 2012;32:4655–62.

PubMed  Google Scholar 

Boire A, Brastianos PK, Garzia L, Valiente M. Brain metastasis. Nat Rev Cancer. 2020;20:4–11.

Article  CAS  PubMed  Google Scholar 

Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22:2865–72.

Article  PubMed  Google Scholar 

Soffietti R, Rudà R, Mutani R. Management of brain metastases. J Neurol. 2002;249:1357–69.

Article  PubMed  Google Scholar 

Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, et al. Cystic brain metastasis outcomes after gamma knife radiation therapy. Adv Radiat Oncol. 2024;9:101304.

Article  CAS  PubMed  Google Scholar 

Patel KR, Prabhu RS, Kandula S, Murphy ES. Cystic brain metastases: an evidence-based review of management. Clin Neurol Neurosurg. 2014;125:30–34.

Google Scholar 

Halasz LM, Rockhill JK. Stereotactic radiosurgery for the management of brain metastases. Neurosurg Clin North Am. 2013;24:521–30.

Google Scholar 

Quigley MR, Fukui O. The impact of cystic metastases on the neurocognition of patients with brain metastases. J Neuro-Oncol. 2010;98:107–15.

Google Scholar 

Fidler IJ, Balasubramanian K, Lin Q, Kim SW. The brain microenvironment and cancer metastasis. Mol Oncol. 2020;14:2531–48.

Google Scholar 

Li YS, Jiang BY, Yang JJ, Zhang XC, Zhong WZ. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non–small-cell lung cancer: a new medium of liquid biopsy. Ann Oncol. 2016;27:1945–50.

Google Scholar 

Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17:223–38.

Article  CAS  PubMed  Google Scholar 

Lam VK, Zhang J, Wu CC, Tran HT, Li L, Diao L, et al. Genotype-specific differences in circulating tumor DNA levels in advanced NSCLC. J Thorac Oncol. 2021;16:601–9.

Article  CAS  PubMed  Google Scholar 

Laguna JC, Pastor B, Nalda I, Hijazo-Pechero S, Teixido C, Potrony M, et al. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications. Br J Cancer. 2024;130:1420–31.

Article  PubMed  PubMed Central  Google Scholar 

Hong TH, Hwang S, Dasgupta A, Abbosh C, Hung T, Bredno J, et al. Clinical utility of tumor-naive presurgical circulating tumor DNA detection in early-stage NSCLC. J Thorac Oncol. 2024;19:1512–24.

Article  CAS  PubMed  Google Scholar 

De Mattos-Arruda L, Mayor R, Ng CKY, Weigelt B, Martínez-Ricarte F, Torrejon D, et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun. 2015;6:8839.

Article  PubMed  PubMed Central  Google Scholar 

Pentsova EI, Shah RH, Tang J, Boire A, Lin X, Kim S, et al. Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid. J Clin Oncol. 2016;34:2404–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Springer S, Zhang M, McMahon KW, Kinde I, Dobbyn L, et al. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc Natl Acad Sci. 2015;112:9704–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan W, Gu W, Nagpal S, Gephart MH, Quake SR. Brain tumor mutations detected in cerebral spinal fluid. Clin Chem. 2015;61:514–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Bai H, Zhang J, Wang Z, Duan J, Cai H, et al. Genetic intratumor heterogeneity remodels the immune microenvironment and induces immune evasion in brain metastasis of lung cancer. J Thorac Oncol. 2024;19:252–72.

Article  CAS  PubMed  Google Scholar 

Blumenthal DT, Fink KL. Liquid biopsy for assessment of response and resistance in primary brain tumors: challenges and prospects. Mol Diagn Ther. 2015;19:339–51.

Google Scholar 

Stallard S, Savelieff MG, Wierzbicki K, Bielas JH. Circulating tumor DNA in cerebrospinal fluid: a window into brain tumor genetic heterogeneity. Oncotarget. 2016;7:44777–90.

Google Scholar 

Piccioni DE, Achrol AS, Kharbanda S, Liebes L, Neuhaus J, Cabral M, et al. Analysis of cell-free circulating tumor DNA in cerebrospinal fluid as a surrogate for medulloblastoma tumor biopsies. Oncotarget. 2019;10:551–60.

Google Scholar 

Icard P, Simula L, Fournel L, Leroy K, Lupo A, Damotte D, et al. The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: therapeutic implications. Drug Resist Updat. 2022;63:100852.

Article  CAS  PubMed  Google Scholar 

Fabbri L, Chakraborty A, Robert C, Vagner S. The plasticity of mRNA translation during cancer progression and therapy resistance. Nat Rev Cancer. 2021;21:558–77.

Article  CAS  PubMed  Google Scholar 

Bedard PL, Hansen AR, Ratain MJ, Siu LL. Tumour heterogeneity in the clinic. Nature. 2013;501:355–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017;168:613–28.

Article  CAS  PubMed  Google Scholar 

Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14:531–48.

Article  CAS  PubMed  Google Scholar 

Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81–94.

Article  CAS